Literature DB >> 2732707

The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation.

M J Hocart1, J S Mackenzie, G A Stewart.   

Abstract

The influence of the route of infection, regime of inoculation and virus preparation on murine IgG subclass responses to the haemagglutinin of influenza A virus were examined. Virus preparations inoculated by the intraperitoneal, intravenous, intramuscular and intranasal routes were found to induce different IgG subclass profiles after a primary and secondary dose. IgG2a was found to be a major contributor to the responses elicited by all virus preparations irrespective of the route of inoculation. The magnitude of the response varied with the number of doses of virus and the route of inoculation; the intravenous and intramuscular routes produced the largest responses after two doses of virus. Evidence for the local production of antibody is presented and the influence of antigen presentation on the induction of different subclass is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732707     DOI: 10.1099/0022-1317-70-4-809

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

Authors:  K H Leong; A J Ramsay; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 2.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Authors:  William C Weldon; Bao-Zhong Wang; Maria P Martin; Dimitrios G Koutsonanos; Ioanna Skountzou; Richard W Compans
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

4.  Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.

Authors:  F R Brennan; T Bellaby; S M Helliwell; T D Jones; S Kamstrup; K Dalsgaard; J I Flock; W D Hamilton
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein.

Authors:  S J Brett; L Dunlop; F Y Liew; J P Tite
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

6.  Optimization of a murine immunization model for study of PF4/heparin antibodies.

Authors:  S Suvarna; R Qi; G M Arepally
Journal:  J Thromb Haemost       Date:  2009-02-24       Impact factor: 5.824

7.  The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin.

Authors:  D M Justewicz; P C Doherty; R G Webster
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin.

Authors:  C A Smith; B C Barnett; D B Thomas; F Temoltzin-Palacios
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

9.  CD83 expression regulates antibody production in response to influenza A virus infection.

Authors:  Madhav Akauliya; Avishekh Gautam; Sony Maharjan; Byoung Kwon Park; Jinsoo Kim; Hyung-Joo Kwon
Journal:  Virol J       Date:  2020-12-10       Impact factor: 4.099

10.  The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans.

Authors:  John L Johnson; Rebecca L Rosenthal; James J Knox; Arpita Myles; Martin S Naradikian; Joanna Madej; Mariya Kostiv; Aaron M Rosenfeld; Wenzhao Meng; Shannon R Christensen; Scott E Hensley; Jonathan Yewdell; David H Canaday; Jinfang Zhu; Adrian B McDermott; Yoav Dori; Max Itkin; E John Wherry; Norbert Pardi; Drew Weissman; Ali Naji; Eline T Luning Prak; Michael R Betts; Michael P Cancro
Journal:  Immunity       Date:  2020-04-29       Impact factor: 31.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.